I can’t wait forever: Treatment of smouldering multiple myeloma (SMM)

From diagnosis to dignity: Palliative care in multiple myeloma

Isatuximab with VRd can benefit newly diagnosed multiple myeloma transplant ineligible patients

Prophylactic tocilizumab prior to infusion of anti-CD19 CAR-T ce may reduce toxicity in older lymphoma patients

Advancements in pharmacovigilance in East Africa

Understanding pharmacovigilance in Namibia

Advances in pharmacovigilance in Nigeria

Enhancing multiple myeloma care in western Kenya

The AMPATH multiple myeloma programme model

AI in multiple myeloma: Recent findings and opportunities

Isatuximab survival benefit over VRd in transplant-ineligible newly diagnosed multiple myeloma

Optimising immunoglobulin dosing can enhance patient outcomes in multiple myeloma